nafoxidine has been researched along with Bone Loss, Osteoclastic in 1 studies
Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with advanced breast cancer may develop acute, severe hypercalcemia when treated with estrogens or antiestrogens." | 1.27 | Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells. ( Eilon, G; Mundy, GR; Saez, S; Valentin-Opran, A, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valentin-Opran, A | 1 |
| Eilon, G | 1 |
| Saez, S | 1 |
| Mundy, GR | 1 |
1 other study available for nafoxidine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.
Topics: Biological Products; Bone Resorption; Breast Neoplasms; Cells, Cultured; Cytokines; Dinoprostone; Es | 1985 |